{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T16:12:19Z","timestamp":1778343139857,"version":"3.51.4"},"reference-count":116,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Vitamin D and erythropoietin (EPO) are kidney-derived hormones classically known for their roles in mineral metabolism and erythropoiesis, respectively. Beyond these functions, growing evidence indicates that both molecules exert broad immunomodulatory effects on innate and adaptive immunity. Vitamin D signalling through the vitamin D receptor shapes dendritic cell maturation, promotes regulatory T-cell induction, and suppresses pro-inflammatory T helper cell responses. Similarly, EPO acts as a pleiotropic cytokine capable of modulating macrophage activation, T-cell proliferation, and inflammatory signalling pathways through EPO receptor-dependent mechanisms.<\/jats:p>\n                  <jats:p>In chronic kidney disease (CKD), reduced renal synthesis of active vitamin D and impaired endogenous EPO production frequently coexist, contributing not only to disturbances in mineral metabolism and anaemia, but possibly also to immune dysregulation. Besides CKD, immune dysregulation is common across diverse nephrological conditions, including immune-mediated nephropathies and transplantation, where inflammatory and alloimmune responses critically influence disease progression and graft outcomes. Increasing experimental and clinical evidence suggests that vitamin D and EPO may modulate these processes and represent potential therapeutic targets.<\/jats:p>\n                  <jats:p>This narrative review summarizes current knowledge on the immunomodulatory properties of vitamin D and EPO, their mechanisms of action on immune cells, and their relevance in kidney disease and transplantation.<\/jats:p>","DOI":"10.1093\/ckj\/sfag120","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:28:52Z","timestamp":1776770932000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond traditional roles: vitamin D and erythropoietin as immune modulators in kidney diseases"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2853-1332","authenticated-orcid":false,"given":"Lorenza","family":"Magagnoli","sequence":"first","affiliation":[{"name":"University of Milan, Milano, Italy; Renal Division, Azienda Socio-Sanitaria Territoriale (ASST) Santi Paolo e Carlo Department of Health Sciences, , Milano ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Bin","sequence":"additional","affiliation":[{"name":"Alma Mater Studiorum\u2013University of Bologna, Bologna, Italy; Nephrology, Dialysis and Kidney Transplant Unit, IRCCS Azienda Ospedaliero, University of Bologna Department of Medical and Surgical Sciences (DIMEC), , Bologna ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7837-0923","authenticated-orcid":false,"given":"Paolo","family":"Cravedi","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai Translational Transplant Research Center, Department of Medicine, , New York, NY ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8494-6252","authenticated-orcid":false,"given":"Mario","family":"Cozzolino","sequence":"additional","affiliation":[{"name":"University of Milan, Milano, Italy; Renal Division, Azienda Socio-Sanitaria Territoriale (ASST) Santi Paolo e Carlo Department of Health Sciences, , Milano ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"2026050912014891500_bib1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MOT.0000000000000594","article-title":"Why some organ allografts are tolerated better than others: new insights for an old question","volume":"24","author":"Hull","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"key":"2026050912014891500_bib2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11914-022-00732-z","article-title":"Vitamin D regulation of immune function","volume":"20","author":"Bikle","year":"2022","journal-title":"Curr Osteoporos Rep"},{"key":"2026050912014891500_bib3","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1111\/ajt.15369","article-title":"Erythropoietin, a multifaceted protein with innate and adaptive immune modulatory activity","volume":"19","author":"Cantarelli","year":"2019","journal-title":"Am J Transplant"},{"key":"2026050912014891500_bib4","doi-asserted-by":"publisher","first-page":"iii35","DOI":"10.1093\/ndt\/gfy175","article-title":"Chronic inflammation in end-stage renal disease and dialysis","volume":"33","author":"Cobo","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2026050912014891500_bib5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","article-title":"Vitamin D metabolism, mechanism of action, and clinical applications","volume":"21","author":"Bikle","year":"2014","journal-title":"Chem Biol"},{"key":"2026050912014891500_bib6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev.nu.11.070191.001201","article-title":"Vitamin D3 receptors: structure and function in transcription","volume":"11","author":"Pike","year":"1991","journal-title":"Annu Rev Nutr"},{"key":"2026050912014891500_bib7","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1210\/en.2006-0946","article-title":"Minireview: vitamin D receptor: new assignments for an already busy receptor","volume":"147","author":"Norman","year":"2006","journal-title":"Endocrinology"},{"key":"2026050912014891500_bib8","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2026050912014891500_bib9","first-page":"419","article-title":"Chronic kidney disease as a systemic inflammatory syndrome: update on mechanisms involved and potential treatment","volume":"11","author":"Tinti","year":"2021","journal-title":"Life (Basel)"},{"key":"2026050912014891500_bib10","doi-asserted-by":"publisher","first-page":"i61","DOI":"10.1093\/ckj\/sfae417","article-title":"Vitamin D: are all compounds equal?","volume":"18","author":"Magagnoli","year":"2025","journal-title":"Clin Kidney J"},{"key":"2026050912014891500_bib11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0092-8674(00)80655-8","article-title":"An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3","volume":"96","author":"Nykjaer","year":"1999","journal-title":"Cell"},{"key":"2026050912014891500_bib12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/13543784.2024.2369307","article-title":"Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs","volume":"33","author":"Magagnoli","year":"2024","journal-title":"Expert Opin Investig Drugs"},{"key":"2026050912014891500_bib13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/sji.12403","article-title":"The active metabolite of vitamin D3 as a potential immunomodulator","volume":"83","author":"Szymczak","year":"2016","journal-title":"Scand J Immunol"},{"key":"2026050912014891500_bib14","doi-asserted-by":"publisher","first-page":"950465","DOI":"10.3389\/fimmu.2023.950465","article-title":"Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review","volume":"14","author":"Ghaseminejad-Raeini","year":"2023","journal-title":"Front Immunol"},{"key":"2026050912014891500_bib15","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.4049\/jimmunol.173.5.2909","article-title":"Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol"},{"key":"2026050912014891500_bib16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1189\/jlb.0609382","article-title":"Human defensins and LL-37 in mucosal immunity","volume":"87","author":"Doss","year":"2010","journal-title":"J Leukoc Biol"},{"key":"2026050912014891500_bib17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12974-023-02705-0","article-title":"Microglia\/macrophages require vitamin D signaling to restrain neuroinflammation and brain injury in a murine ischemic stroke model","volume":"20","author":"Cui","year":"2023","journal-title":"J Neuroinflammation"},{"key":"2026050912014891500_bib18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular mechanisms that influence the macrophage M1\u2013M2 polarization balance","volume":"5","author":"Wang","year":"2014","journal-title":"Front Immunol"},{"key":"2026050912014891500_bib19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s42003-021-01943-3","article-title":"Vitamin D upregulates the macrophage complement receptor immunoglobulin in innate immunity to microbial pathogens","volume":"4","author":"Small","year":"2021","journal-title":"Commun Biol"},{"key":"2026050912014891500_bib20","doi-asserted-by":"publisher","first-page":"19450","DOI":"10.1074\/jbc.M113.467670","article-title":"Vitamin D receptor inhibits nuclear factor \u03baB activation by interacting with I\u03baB kinase beta protein","volume":"288","author":"Chen","year":"2013","journal-title":"J Biol Chem"},{"key":"2026050912014891500_bib21","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","article-title":"1\u03b1,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation","volume":"164","author":"Penna","year":"2000","journal-title":"J Immunol"},{"key":"2026050912014891500_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/B978-0-12-380995-7.00004-5","article-title":"How tolerogenic dendritic cells induce regulatory T cells","volume":"108","author":"Maldonado","year":"2010","journal-title":"Adv Immunol"},{"key":"2026050912014891500_bib23","doi-asserted-by":"publisher","first-page":"e210554","DOI":"10.1530\/EC-21-0554","article-title":"Autoimmune disease and interconnections with vitamin D","volume":"11","author":"Fletcher","year":"2022","journal-title":"Endocr Connect"},{"key":"2026050912014891500_bib24","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.4049\/jimmunol.168.3.1181","article-title":"1,25-dihydroxyvitamin D3 inhibits IFN-\u03b3 and IL-4 levels during in vitro polarization of primary murine CD4+ T cells","volume":"168","author":"Staeva-Vieira","year":"2002","journal-title":"J Immunol"},{"key":"2026050912014891500_bib25","doi-asserted-by":"publisher","first-page":"38751","DOI":"10.1074\/jbc.C110.185777","article-title":"Vitamin D suppresses Th17 cytokine production by inducing C\/EBP homologous protein (CHOP) expression","volume":"285","author":"Chang","year":"2010","journal-title":"J Biol Chem"},{"key":"2026050912014891500_bib26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.molimm.2017.09.006","article-title":"1,25(OH)2D3 induces regulatory T cell differentiation by influencing the VDR\/PLC-\u03b31\/TGF-\u03b21\/pathway","volume":"91","author":"Zhou","year":"2017","journal-title":"Mol Immunol"},{"key":"2026050912014891500_bib27","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1\u03b1,25-Dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells","volume":"167","author":"Boonstra","year":"2001","journal-title":"J Immunol"},{"key":"2026050912014891500_bib28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jneuroim.2016.09.018","article-title":"Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFN\u03b2; the SOLARIUM study","volume":"300","author":"Muris","year":"2016","journal-title":"J Neuroimmunol"},{"key":"2026050912014891500_bib29","first-page":"407","article-title":"The impact of vitamin D supplementation on the IFN\u03b3-IP10 axis in women with Hashimoto\u2019s thyroiditis treated with levothyroxine: a double-blind randomized placebo-controlled trial","volume":"21","author":"Robat-Jazi","year":"2022","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"2026050912014891500_bib30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/0961203314559090","article-title":"Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D","volume":"24","author":"Piantoni","year":"2015","journal-title":"Lupus"},{"key":"2026050912014891500_bib31","doi-asserted-by":"publisher","first-page":"R221","DOI":"10.1186\/ar4060","article-title":"Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation","volume":"14","author":"Terrier","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2026050912014891500_bib32","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.3390\/nu11092185","article-title":"Influence of vitamin D on islet autoimmunity and beta-cell function in type 1 diabetes","volume":"11","author":"Infante","year":"2019","journal-title":"Nutrients"},{"key":"2026050912014891500_bib33","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","article-title":"Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol"},{"key":"2026050912014891500_bib34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/nyas.12440","article-title":"Vitamin D effects on B cell function in autoimmunity","volume":"1317","author":"Rolf","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"2026050912014891500_bib35","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1177\/1352458511412655","article-title":"Effect of vitamin D3 supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis","volume":"17","author":"Knippenberg","year":"2011","journal-title":"Mult Scler"},{"key":"2026050912014891500_bib36","first-page":"e93853","article-title":"Serum vitamin D level and disease activity in patients with systemic lupus erythematosus","volume":"17","author":"Oo","year":"2025","journal-title":"Cureus"},{"key":"2026050912014891500_bib37","doi-asserted-by":"publisher","first-page":"1252594","DOI":"10.3389\/fped.2023.1252594","article-title":"Serum 25(OH)D levels are associated with disease activity and renal involvement in initial-onset childhood systemic lupus erythematosus","volume":"11","author":"Jiang","year":"2023","journal-title":"Front Pediatr"},{"key":"2026050912014891500_bib38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jmii.2015.12.005","article-title":"Correlation between disease activity of pediatric-onset systemic lupus erythematosus and level of vitamin D in Taiwan: a case-cohort study","volume":"51","author":"Lin","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"2026050912014891500_bib39","doi-asserted-by":"publisher","first-page":"rkad021","DOI":"10.1093\/rap\/rkad021","article-title":"Vitamin D status in ANCA-associated vasculitis","volume":"7","author":"Doubelt","year":"2023","journal-title":"Rheumatol Adv Pract"},{"key":"2026050912014891500_bib40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12882-016-0378-4","article-title":"Vitamin D deficiency may predict a poorer outcome of IgA nephropathy","volume":"17","author":"Li","year":"2016","journal-title":"BMC Nephrol"},{"key":"2026050912014891500_bib41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1471-4914(02)02294-3","article-title":"The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents","volume":"8","author":"Mathieu","year":"2002","journal-title":"Trends Mol Med"},{"key":"2026050912014891500_bib42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000353587","article-title":"Interferon-\u03b3 reduces the proliferation of primed human renal tubular cells","volume":"4","author":"Garc\u00eda-S\u00e1nchez","year":"2014","journal-title":"Nephron Extra"},{"key":"2026050912014891500_bib43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1053\/j.ackd.2019.01.004","article-title":"Immune dysfunction and risk of infection in chronic kidney disease","volume":"26","author":"Syed-Ahmed","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"2026050912014891500_bib44","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/ijms21010263","article-title":"Inflammation and oxidative stress in chronic kidney disease\u2014potential therapeutic role of minerals, vitamins and plant-derived metabolites","volume":"21","author":"Rapa","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026050912014891500_bib45","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1053\/ajkd.2001.27697","article-title":"A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol","volume":"38","author":"Moe","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"2026050912014891500_bib46","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension"},{"key":"2026050912014891500_bib47","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1093\/ndt\/gfs138","article-title":"Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D","volume":"27","author":"Marckmann","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2026050912014891500_bib48","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/ejcn.2012.217","article-title":"Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease","volume":"67","author":"Alvarez","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"2026050912014891500_bib49","first-page":"77","article-title":"Double treatment with paricalcitol-associated calcifediol and cardiovascular risk biomarkers in haemodialysis","volume":"33","author":"Pinera-Haces","year":"2013","journal-title":"Nefrologia"},{"key":"2026050912014891500_bib50","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jdiacomp.2015.01.004","article-title":"Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease","volume":"29","author":"Thethi","year":"2015","journal-title":"J Diabetes Complications"},{"key":"2026050912014891500_bib51","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.clnu.2016.04.014","article-title":"Effect of cholecalciferol on vitamin D-regulatory proteins in monocytes and on inflammatory markers in dialysis patients: a randomized controlled trial","volume":"35","author":"Meireles","year":"2016","journal-title":"Clin Nutr"},{"key":"2026050912014891500_bib52","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.2215\/CJN.01870217","article-title":"Cholecalciferol, calcitriol, and vascular function in CKD: a randomized, double-blind trial","volume":"12","author":"Kendrick","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026050912014891500_bib53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12882-017-0576-8","article-title":"Vitamin D receptor activation reduces inflammatory cytokines and plasma MicroRNAs in moderate chronic kidney disease\u2014a randomized trial","volume":"18","author":"Mansouri","year":"2017","journal-title":"BMC Nephrol"},{"key":"2026050912014891500_bib54","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/1744-9987.13722","article-title":"Efficacy of high versus conventional dose of ergocalciferol supplementation on serum 25-hydroxyvitamin D and interleukin-6 levels among hemodialysis patients with vitamin D deficiency: a multicenter, randomized, controlled study","volume":"26","author":"Nata","year":"2022","journal-title":"Ther Apher Dial"},{"key":"2026050912014891500_bib55","doi-asserted-by":"publisher","first-page":"2577271","DOI":"10.1080\/07853890.2025.2577271","article-title":"Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial","volume":"57","author":"Nugroho","year":"2025","journal-title":"Ann Med"},{"key":"2026050912014891500_bib56","first-page":"1664","article-title":"The role of vitamin D in kidney transplantation outcomes: a systematic review","volume":"12","author":"Koimtzis","year":"2022","journal-title":"Life (Basel)"},{"key":"2026050912014891500_bib57","doi-asserted-by":"publisher","first-page":"e15187","DOI":"10.1111\/tan.15187","article-title":"25-hydroxyvitamin D sufficiency is associated with lower de novo anti-HLA donor specific antibody and better kidney transplant outcomes","volume":"103","author":"Bakis","year":"2024","journal-title":"HLA"},{"key":"2026050912014891500_bib58","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.34067\/KID.0000000942","article-title":"Association of post-transplant circulating 25-hydroxyvitamin D and long-term patient and graft outcomes among kidney transplant recipients: the Wisconsin Allograft Recipient Database","volume-title":"Kidney360","author":"Yuan","year":"2025"},{"key":"2026050912014891500_bib59","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/ejcts\/ezs150","article-title":"1,25-Dihydroxycholecalciferol with low-calcium diet reduces acute rejection in rat lung allotransplantation","volume":"42","author":"Kubisa","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026050912014891500_bib60","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.3390\/nu11122937","article-title":"The role of vitamin D and omega-3 PUFAs in islet transplantation","volume":"11","author":"Infante","year":"2019","journal-title":"Nutrients"},{"key":"2026050912014891500_bib61","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.healun.2017.03.008","article-title":"High-dose vitamin D after lung transplantation: a randomized trial","volume":"36","author":"Vos","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2026050912014891500_bib62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1084\/jem.20122760","article-title":"Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration","volume":"210","author":"Broxmeyer","year":"2013","journal-title":"J Exp Med"},{"key":"2026050912014891500_bib63","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1182\/blood.V94.6.1864","article-title":"Regulation of the erythropoietin gene","volume":"94","author":"Ebert","year":"1999","journal-title":"Blood"},{"key":"2026050912014891500_bib64","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev.med.60.050307.110718","article-title":"Erythropoietin in cancer patients","volume":"60","author":"Glaspy","year":"2009","journal-title":"Annu Rev Med"},{"key":"2026050912014891500_bib65","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1113\/jphysiol.2010.195057","article-title":"Regulation of erythropoietin production","volume":"589","author":"Jelkmann","year":"2011","journal-title":"J Physiol"},{"key":"2026050912014891500_bib66","doi-asserted-by":"publisher","first-page":"1759091419871420","DOI":"10.1177\/1759091419871420","article-title":"Erythropoietin as a neuroprotective molecule: an overview of its therapeutic potential in neurodegenerative diseases","volume":"11","author":"Rey","year":"2019","journal-title":"ASN Neuro"},{"key":"2026050912014891500_bib67","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41419-020-2276-8","article-title":"Erythropoietin and its derivatives: from tissue protection to immune regulation","volume":"11","author":"Peng","year":"2020","journal-title":"Cell Death Dis"},{"key":"2026050912014891500_bib68","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2310\/JIM.0b013e3181ed30bf","article-title":"Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?","volume":"59","author":"Hand","year":"2011","journal-title":"J Investig Med"},{"key":"2026050912014891500_bib69","first-page":"163","article-title":"The effect of erythropoietin on normal and neoplastic cells","volume":"6","author":"Elliott","year":"2012","journal-title":"Biologics"},{"key":"2026050912014891500_bib70","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/sj.ki.5001546","article-title":"Discovering erythropoietin\u2019s extra-hematopoietic functions: biology and clinical promise","volume":"70","author":"Brines","year":"2006","journal-title":"Kidney Int"},{"key":"2026050912014891500_bib71","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2119\/molmed.2011.00414","article-title":"The receptor that tames the innate immune response","volume":"18","author":"Brines","year":"2012","journal-title":"Mol Med"},{"key":"2026050912014891500_bib72","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jvs.2013.06.054","article-title":"Potential role of erythropoietin receptors and ligands in attenuating apoptosis and inflammation in critical limb ischemia","volume":"60","author":"Joshi","year":"2014","journal-title":"J Vasc Surg"},{"key":"2026050912014891500_bib73","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jfma.2018.03.017","article-title":"Physiology and pathophysiology of renal erythropoietin-producing cells","volume":"117","author":"Shih","year":"2018","journal-title":"J Formos Med Assoc"},{"key":"2026050912014891500_bib74","doi-asserted-by":"publisher","first-page":"e0134104","DOI":"10.1371\/journal.pone.0134104","article-title":"Pentoxifylline for anemia in chronic kidney disease: a systematic review and meta-analysis","volume":"10","author":"Bolignano","year":"2015","journal-title":"PLoS One"},{"key":"2026050912014891500_bib75","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3949\/ccjm.83a.15065","article-title":"Anemia of chronic kidney disease: treat it, but not too aggressively","volume":"83","author":"Nakhoul","year":"2016","journal-title":"Cleve Clin J Med"},{"key":"2026050912014891500_bib76","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.kint.2023.05.009","article-title":"Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"104","author":"Ku","year":"2023","journal-title":"Kidney Int"},{"key":"2026050912014891500_bib77","doi-asserted-by":"publisher","first-page":"110583","DOI":"10.1016\/j.cellsig.2022.110583","article-title":"Indoxyl sulfate impairs erythropoiesis at BFU-E stage in chronic kidney disease","volume":"104","author":"Hamza","year":"2023","journal-title":"Cell Signal"},{"key":"2026050912014891500_bib78","doi-asserted-by":"publisher","first-page":"e0196684","DOI":"10.1371\/journal.pone.0196684","article-title":"The hypoxia inducible factor\/erythropoietin (EPO)\/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia","volume":"13","author":"Landau","year":"2018","journal-title":"PLoS One"},{"key":"2026050912014891500_bib79","doi-asserted-by":"publisher","first-page":"13012","DOI":"10.1038\/s41598-017-13046-3","article-title":"Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis","volume":"7","author":"Nairz","year":"2017","journal-title":"Sci Rep"},{"key":"2026050912014891500_bib80","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.immuni.2011.01.002","article-title":"Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-\u03baB-inducible immune pathways","volume":"34","author":"Nairz","year":"2011","journal-title":"Immunity"},{"key":"2026050912014891500_bib81","doi-asserted-by":"publisher","first-page":"e2725","DOI":"10.1038\/cddis.2017.104","article-title":"Erythropoietin protects against rhabdomyolysis-induced acute kidney injury by modulating macrophage polarization","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis"},{"key":"2026050912014891500_bib82","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/TP.0000000000001026","article-title":"A nonhematopoietic erythropoietin analogue, ARA 290, inhibits macrophage activation and prevents damage to transplanted islets","volume":"100","author":"Watanabe","year":"2016","journal-title":"Transplantation"},{"key":"2026050912014891500_bib83","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1038\/s41598-018-20520-z","article-title":"Erythropoietin signaling increases choroidal macrophages and cytokine expression, and exacerbates choroidal neovascularization","volume":"8","author":"Bretz","year":"2018","journal-title":"Sci Rep"},{"key":"2026050912014891500_bib84","doi-asserted-by":"publisher","first-page":"10379","DOI":"10.1038\/s41598-017-11082-7","article-title":"Erythropoietin enhances Kupffer cell number and activity in the challenged liver","volume":"7","author":"Gilboa","year":"2017","journal-title":"Sci Rep"},{"key":"2026050912014891500_bib85","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1111\/jcmm.13608","article-title":"Non-erythropoietic erythropoietin-derived peptide protects mice from systemic lupus erythematosus","volume":"22","author":"Huang","year":"2018","journal-title":"J Cell Mol Med"},{"key":"2026050912014891500_bib86","doi-asserted-by":"publisher","first-page":"e158856","DOI":"10.1172\/jci.insight.158856","article-title":"Linking erythropoietin to Treg-dependent allograft survival through myeloid cells","volume":"7","author":"Horwitz","year":"2022","journal-title":"JCI Insight"},{"key":"2026050912014891500_bib87","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep"},{"key":"2026050912014891500_bib88","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2016.01.002","article-title":"Erythropoeitin signaling in macrophages promotes dying cell clearance and immune tolerance","volume":"44","author":"Luo","year":"2016","journal-title":"Immunity"},{"key":"2026050912014891500_bib89","doi-asserted-by":"publisher","first-page":"12177","DOI":"10.1038\/ncomms12177","article-title":"Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution","volume":"7","author":"Luo","year":"2016","journal-title":"Nat Commun"},{"key":"2026050912014891500_bib90","doi-asserted-by":"publisher","first-page":"eadr3026","DOI":"10.1126\/science.adr3026","article-title":"Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity","volume":"388","author":"Chiu","year":"2025","journal-title":"Science"},{"key":"2026050912014891500_bib91","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.exphem.2008.07.010","article-title":"Erythropoietin effects on dendritic cells: potential mediators in its function as an immunomodulator?","volume":"36","author":"Sagiv","year":"2008","journal-title":"Exp Hematol"},{"key":"2026050912014891500_bib92","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41586-025-09824-z","article-title":"Erythropoietin receptor on cDC1s dictates immune tolerance","volume":"650","author":"Zhang","year":"2026","journal-title":"Nature"},{"key":"2026050912014891500_bib93","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3324\/haematol.2010.025015","article-title":"Macrophages as novel target cells for erythropoietin","volume":"95","author":"Lifshitz","year":"2010","journal-title":"Haematologica"},{"key":"2026050912014891500_bib94","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1681\/ASN.2016101100","article-title":"Erythropoietin receptor-mediated molecular crosstalk promotes T cell immunoregulation and transplant survival","volume":"28","author":"Purroy","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2026050912014891500_bib95","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1681\/ASN.2013090945","article-title":"Immunosuppressive effects of erythropoietin on human alloreactive T cells","volume":"25","author":"Cravedi","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2026050912014891500_bib96","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/10799893.2011.578646","article-title":"Flow cytometric analysis of STAT5 phosphorylation and CD95 expression in CD4+ T lymphocytes treated with recombinant human erythropoietin","volume":"31","author":"Lisowska","year":"2011","journal-title":"J Recept Signal Transduct Res"},{"key":"2026050912014891500_bib97","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1172\/JCI65325","article-title":"SHP-1 phosphatase activity counteracts increased T cell receptor affinity","volume":"123","author":"Hebeisen","year":"2013","journal-title":"J Clin Invest"},{"key":"2026050912014891500_bib98","doi-asserted-by":"publisher","first-page":"e127428","DOI":"10.1172\/jci.insight.127428","article-title":"Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease","volume":"5","author":"Donadei","year":"2019","journal-title":"JCI Insight"},{"key":"2026050912014891500_bib99","doi-asserted-by":"publisher","first-page":"e1924","DOI":"10.1371\/journal.pone.0001924","article-title":"Erythropoietin: a potent inducer of peripheral immuno\/inflammatory modulation in autoimmune EAE","volume":"3","author":"Yuan","year":"2008","journal-title":"PLoS One"},{"key":"2026050912014891500_bib100","doi-asserted-by":"publisher","first-page":"102629","DOI":"10.1016\/j.jaut.2021.102629","article-title":"Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis","volume":"119","author":"McEachern","year":"2021","journal-title":"J Autoimmun"},{"key":"2026050912014891500_bib101","doi-asserted-by":"publisher","first-page":"15845","DOI":"10.3389\/ti.2025.15845","article-title":"Increased Treg in kidney transplant recipients with erythrocytosis","volume":"38","author":"Bigatti","year":"2025","journal-title":"Transpl Int"},{"key":"2026050912014891500_bib102","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1681\/ASN.2021010098","article-title":"Erythropoietin reduces auto- and alloantibodies by inhibiting T follicular helper cell differentiation","volume":"32","author":"Guglielmo","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2026050912014891500_bib103","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fmed.2020.00047","article-title":"Advances in understanding the effects of erythropoietin on renal fibrosis","volume":"7","author":"Zhang","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"2026050912014891500_bib104","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.juro.2008.10.105","article-title":"Erythropoietin attenuates renal injury in an experimental model of rat unilateral ureteral obstruction via anti-inflammatory and anti-apoptotic effects","volume":"181","author":"Chang","year":"2009","journal-title":"J Urol"},{"key":"2026050912014891500_bib105","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1007\/s10753-018-0832-5","article-title":"Erythropoietin treatment ameliorates lupus nephritis of MRL\/lpr mice","volume":"41","author":"Zhang","year":"2018","journal-title":"Inflammation"},{"key":"2026050912014891500_bib106","doi-asserted-by":"publisher","first-page":"1195662","DOI":"10.3389\/fimmu.2023.1195662","article-title":"Endogenous erythropoietin has immunoregulatory functions that limit the expression of autoimmune kidney disease in mice","volume":"14","author":"Bin","year":"2023","journal-title":"Front Immunol"},{"key":"2026050912014891500_bib107","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2249.2010.04238.x","article-title":"Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis","volume":"162","author":"Chen","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2026050912014891500_bib108","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.bbrc.2007.05.207","article-title":"Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress","volume":"359","author":"Katavetin","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"2026050912014891500_bib109","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1093\/ndt\/gfn247","article-title":"HO-1 induction ameliorates experimental murine membranous nephropathy: anti-oxidative, anti-apoptotic and immunomodulatory effects","volume":"23","author":"Wu","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2026050912014891500_bib110","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1146\/annurev-immunol-102119-073855","article-title":"Trained immunity: reprogramming innate immunity in health and disease","volume":"39","author":"Bekkering","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"2026050912014891500_bib111","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41581-022-00633-5","article-title":"Trained immunity\u2014basic concepts and contributions to immunopathology","volume":"19","author":"Ochando","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"2026050912014891500_bib112","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/ajt.15620","article-title":"Trained immunity in organ transplantation","volume":"20","author":"Ochando","year":"2020","journal-title":"Am J Transplant"},{"key":"2026050912014891500_bib113","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1097\/TP.0000000000004978","article-title":"Targeting macrophages in organ transplantation: a step toward personalized medicine","volume":"108","author":"Owen","year":"2024","journal-title":"Transplantation"},{"key":"2026050912014891500_bib114","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ajt.2025.10.013","article-title":"Erythropoietin prolongs graft survival in mice by counteracting trained immunity","volume":"26","author":"Bin","year":"2026","journal-title":"Am J Transplant"},{"key":"2026050912014891500_bib115","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"2026050912014891500_bib116","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1200\/JCO.2015.63.5649","article-title":"A randomized, open-label, multicenter, phase III study of epoetin alfa versus best standard of care in anemic patients with metastatic breast cancer receiving standard chemotherapy","volume":"34","author":"Leyland-Jones","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag120\/68179245\/sfag120.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/5\/sfag120\/68179245\/sfag120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/5\/sfag120\/68179245\/sfag120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T16:01:57Z","timestamp":1778342517000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag120\/8664054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":116,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag120","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,28]]},"article-number":"sfag120"}}